Roche Registration Ltd

Φαρμακευτικά σκευάσματα

Η εταιρεία έχει λάβει από τις αρμόδιες αρχές άδεια κυκλοφορίας για τα παρακάτω φαρμακευτικά σκευάσματα:

Κωδικός	Όνομα	Κ	Ν.Τ.	Χ.Τ.	Λ.Τ.	Κάτοχος άδειας
31623.01.02	ALECENSA CAPS 150MG/CAP Φιάλη (HDPE) x240 καψάκια		4.692,21	5.218,82	5.642,59	Roche Registration Ltd
22731.02.02	BONDRONAT C/S.SOL.IN 2MG/2ML BTx1VIALx2ML		66,72	76,69	108,14	Roche Registration Ltd
26978.02.02	BONVIVA F.C.TAB 150 MG/TAB BTx3(BLIST PVC/PVDC)		36,02	41,40	58,38	Roche Registration Ltd
30333.01.02	ESBRIET CAPS 267MG/CAP BTx252 (4x63) σε PVC/PE/PCTFE/alu blister		1.745,17	1.941,00	2.124,32	Roche Registration Ltd
30333.01.01	ESBRIET CAPS 267MG/CAP BTx63 (1x21) και (1x42) σε PVC/PE/PCTFE/alu blister		434,66	483,43	558,56	Roche Registration Ltd
30333.02.07	ESBRIET F.C.TAB 267MG/TAB 84 δισκία σε BLISTER (PVC/Aclar(PCRFE))		438,14	487,31	563,04	Roche Registration Ltd
22874.01.01	INVIRASE 200MG/CAP CAPS FLx270		194,47	223,53	270,01	Roche Registration Ltd
22896.06.01	NEORECORMON (MULTIDOSE) PS.INJ.SOL 50000 IU/VIAL BTX1VIAL+1AMPX10ML		176,09	179,61	221,89	Roche Registration Ltd
22896.15.01	NEORECORMON 10000 IU/0,6MLPREF.S INJ.SO.PFS BTx1PREF.SYR.x0,6ML		35,22	40,48	44,38	Roche Registration Ltd
22896.12.01	NEORECORMON INJ.SO.PFS 2000 IU/0,3MLPREF.SY BTx1PREF.SYR.x0,3ML		7,48	7,63	9,43	Roche Registration Ltd
22896.12.02	NEORECORMON INJ.SO.PFS 2000 IU/0,3MLPREF.SY BTx6PREF.SYRx0,3ML		43,96	44,84	55,40	Roche Registration Ltd
22896.16.01	NEORECORMON INJ.SO.PFS 20000 IU/0,6MLPREF.S BTx1PREF.SYR.x0,6ML		70,44	71,85	88,76	Roche Registration Ltd
22896.16.02	NEORECORMON INJ.SO.PFS 20000 IU/0,6MLPREF.S BTx6 PREF.SYR.x0,6ML		422,61	431,06	491,03	Roche Registration Ltd
22896.20.01	NEORECORMON INJ.SO.PFS 30.000IU/0,6ML PREF.SY BTx1PF.SYR.x0,6ML		109,25	111,44	137,67	Roche Registration Ltd
22896.13.01	NEORECORMON INJ.SO.PFS 3000 IU/0,3MLPREF.SY BTx1PREF.SYRx0,3ML		10,63	10,84	13,39	Roche Registration Ltd
22896.13.02	NEORECORMON INJ.SO.PFS 3000 IU/0,3MLPREF.SY BTx6PREF.SYR.x0,3ML		65,55	66,86	82,60	Roche Registration Ltd
22896.18.02	NEORECORMON INJ.SO.PFS 4000 IU/0,3MLPREF.SY BTx6PF.SYR.x0,3ML		87,23	88,97	109,91	Roche Registration Ltd
22896.10.01	NEORECORMON INJ.SO.PFS 500 IU/0,3ML PREF.SY BTX1PREF.SYR.X0,3ML		3,47	3,54	4,37	Roche Registration Ltd
22896.10.02	NEORECORMON INJ.SO.PFS 500 IU/0,3ML PREF.SY BTX6PREF.SYR.X0,3ML		16,49	16,82	20,78	Roche Registration Ltd
22896.14.01	NEORECORMON INJ.SO.PFS 5000 IU/0,3MLPREF.SY BTx1PREF.SYR.x0,3ML		17,61	17,96	22,19	Roche Registration Ltd
22896.19.02	NEORECORMON INJ.SO.PFS 6000 IU/0,3ML PREF.SY BTx6PREF.SYR.x0,3ML		130,02	132,62	163,84	Roche Registration Ltd
25173.05.02	PEGASYS IN.SO.PF.P 135MCG/0,5ML PF.PEN BTx4PF.PEN.x0,5ML		420,44	467,62	540,29	Roche Registration Ltd
25173.06.02	PEGASYS IN.SO.PF.P 180MCG/0,5ML PF.PEN BTx4PF.PEN.x0,5ML		484,32	538,66	616,66	Roche Registration Ltd
25173.03.01	PEGASYS INJ.SOL 135MCG/0,5ML BTx1PF.SYR.x0,5ML+1 INJ.N		105,11	120,82	148,56	Roche Registration Ltd
28716.01.04	ROACTEMRA 20MG/ML BTx4 VIALS x10ML		1.114,87	1.137,17	1.243,04	Roche Registration Ltd
28716.01.06	ROACTEMRA 20MG/ML BTx4 VIALS x20ML		2.196,26	2.240,19	2.417,75	Roche Registration Ltd
28716.01.02	ROACTEMRA C/S.SOL.IN 20MG/ML BTx4 VIALS x4ML		439,30	488,59	564,51	Roche Registration Ltd
25757.02.01	TAMIFLU PD.ORA.SUS 12MG/ML BTx1Φιάλη (γυάλινη)		11,85	13,62	18,77	Roche Registration Ltd
25757.05.01	TAMIFLU PD.ORA.SUS 6MG/ML BT x 1Φιάλη (γυάλινη) x 13G		7,51	8,63	11,89	Roche Registration Ltd
27001.01.01	TARCEVA 25mg/TAB F.C.TAB BT x 30 (BLISTERS, PVC/Alu)		374,19	430,10	438,43	Roche Registration Ltd
23551.03.01	VIRACEPT F.C.TAB 250MG/TAB FLX270		223,74	257,17	305,84	Roche Registration Ltd
23551.01.01	VIRACEPT ORAL.PD 50MG/G FLX144G		30,22	34,74	48,99	Roche Registration Ltd
23457.01.02	XENICAL CAPS 120MG/CAP BTX42(BLISTERS)		13,19	15,16	21,38	Roche Registration Ltd
23852.02.01	ZENAPAX 1 BOX * 3 VIAL * 5 ML					Roche Registration Ltd